A machine learning–based tool accurately predicted risk for recurrent inflammatory activity after DMT discontinuation in MS, highlighting its potential to guide personalized treatment decisions.

Patients with primary progressive MS more commonly exhibited delays in overall disability progression following treatment with ocrelizumab vs placebo.

Sleep disorders are highly prevalent among individuals with multiple sclerosis (MS), affecting nearly half of the patient population, according to study results presented at the European Committee for ...

Almost half of women with MS remain untreated during family planning, though ocrelizumab is the most commonly used DMT in this population.

The majority of infections in multiple sclerosis (MS) are reported in non-neurology practices, according to study results presented at the European Committee for Treatment and Research in Multiple ...

Elevated vitamin D levels may lower the risk for MS in White individuals, though this association is less pronounced in Black individuals.

Temperature sensitivity is associated with disease duration, dysautonomia, and quality of life in patients with multiple sclerosis.

Compared with other measures of hypertension, the American Heart Association’s stage II hypertension category had the strongest association with disability worsening in patients with multiple ...

A new federal vaccine panel appointed by US Health Secretary Robert F Kennedy Jr has recommended tighter restrictions on COVID-19 vaccines.

The 2024 McDonald criteria improve early MS diagnosis with higher sensitivity and accuracy, but lower specificity in real-world settings.

A deep learning model was able to determine the presence or absence of distinct autoimmune neuroinflammatory disorders.

Periodic limb movements occur frequently among persons with epilepsy but do not occur more often than among those with OSA.